In Summary
Recursion Pharmaceuticals receives a fresh sell signal in week 1, with signal strength low at 22 out of 100 and fading. Our model flags trading as not recommended: opening a new short in these conditions carries elevated risk. The asset continues to be monitored week by week.
Fresh sell signal
·1st week from start
·US stocks
·T2
IQS Phase
73
in tension
Signal Strength
22
low · fading
Sizing
MINIMUM
Ranking
#34 / 80
New us stocks
restricted Platinum content